John Slack was Vice
President, International Development at OSI
Pharmaceuticals and also served as the Tarceva
International Project Team Leader.
served as Managing Director of Aston Molecules following
its acquisition by OSI Pharmaceuticals. John managed the
acquisition of Aston Molecules by OSI Pharmaceuticals
and prior to that managed the financing and spinout of
Aston Molecules from Aston University.
Prior to Aston
Molecules, John held academic positions within the
Experimental Chemotherapy Group, Department of
Pharmaceutical Sciences at Aston University, the
Department of Therapeutics and Clinical Pharmacology at
Birmingham University and the Department of Chemical
Pathology at King's College, London.
John has now co-founded PharMomentum Ltd as a “hands
on”, problem solving consultancy group.